Followers | 534 |
Posts | 106818 |
Boards Moderated | 1 |
Alias Born | 11/20/2007 |
Friday, April 12, 2013 1:21:16 PM
So let me make it clear for everyone who is thinking of buying CVSL. This is another fact that says our CEO, John Rochon, is the real deal:
Says here Richmont is the largest shareholder of Avon Products Inc:
How connected is Mr. Rochon to this? Same paragraph opening sentence:
https://www.jamesonbank.com/about-us/board-members/john-p-rochon
Avon Products Inc. trades on the NYSE currently at $21.00 a share with an O/S of 432,280,018:
http://www.otcmarkets.com/stock/AVP/company-info
Although we don't know how many shares of AVP Richmont owns, we know they withdrew a $10.7 billion bid last year and, instead, might purchase %25 or more of the company:
http://www.bloomberg.com/news/2012-05-15/richmont-said-still-interested-in-all-or-part-of-avon.html
Well, tell me that $CVSL doesn't look like it will be multi-dollars in the near future. And, by the way, these articles and press releases are all up to date. And not to mention, we just took majority control in a $100million company...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM